A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight
NCT06352892
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Maridebart Cafraglutide
Sponsor
Amgen